T1	Participants 104 132	peripheral pulmonary lesions
T2	Participants 278 313	peripheral pulmonary lesions (PPLs)
T3	Participants 485 546	Two hundred two patients with PPLs and positive EBUS findings
T4	Participants 911 1005	182 patients (94 in the EBUS CDPs group and 88 in the EBUS-TBNA plus CDPs group) were analyzed
T5	Participants 1726 1730	PPLs
